When Non-Surgical Hair Restoration Comes First: Medical Treatment Before Any Transplant Talk

The photo that finally did it was taken from behind, at a family dinner, by a nephew who meant nothing by it. There it was: a pale island of scalp at the crown that the bathroom mirror had never shown. Within a week the browser history filled up with graft counts, surgeon galleries and phrases like “permanent solution.” Almost none of it mentioned a blood test.

That gap is exactly where the conversation about non surgical hair restoration before transplant belongs. Pattern hair loss is a slow, ongoing process, and a transplant is a one-time relocation of hair from a limited supply. Skilled surgeons know this, which is why the ones worth listening to often spend the first appointment talking about medicine, timelines and realistic expectations rather than needles.

This explainer walks through what a medical workup actually involves, how the non-surgical options work at the level of the follicle, what the evidence does and does not show, and why the order of treatment matters as much as the treatment itself.

Why non surgical hair restoration before transplant is the usual sequence

Think of the scalp as a garden with a fixed number of seeds. A transplant does not add seeds; it moves them from the back and sides, where follicles tend to resist hormonal miniaturization, to the front and crown where they are missing. The catch is that the untreated hair around the new grafts keeps thinning on its own schedule. Without something to slow that background loss, a person can end up with a tidy transplanted hairline sitting in front of a widening gap.

Medical treatment addresses the process rather than the map. According to Mayo Clinic, the most common cause of hair loss is hereditary pattern loss, which is gradual and predictable, and treatments for it aim to slow the loss or promote regrowth rather than to reverse it completely. Starting there does three useful things. It shows whether the loss responds to medicine at all. It gives the treating team a stable baseline so a future surgical plan is built on a scalp that is no longer changing quickly. And it protects the donor area, because every graft used to chase a moving target is a graft no longer available later.

There is a diagnostic reason too. Not every thinning scalp is pattern hair loss. Shedding from illness, childbirth, crash dieting, thyroid disease, iron deficiency or certain medicines can look alarmingly similar in the mirror, and the National Library of Medicine’s MedlinePlus lists these among the recognized causes. Transplanting hair into a scalp that is shedding for a reversible reason wastes grafts and can delay the treatment that would have actually helped.

None of this means surgery is wrong. It means surgery is a later chapter, and the medical chapter is where the story usually has to begin.

What actually happens during a medical hair loss evaluation

The first visit is quieter than most people expect. A clinician will ask when the thinning started, whether it came on gradually or in a rush, who else in the family has it, what medicines and supplements are being taken, and what has changed in health, weight or stress over the previous year. A careful history often points to the diagnosis before any test is ordered.

The scalp examination looks at pattern. Hereditary loss tends to spare the back and sides and concentrate at the temples and crown in men, or spread across the top in women while keeping the front hairline. A gentle pull test, in which a small bundle of hair is tugged to see how many strands release, helps judge whether active shedding is under way. Many clinicians use a handheld magnifier called a dermatoscope to look for miniaturized hairs, the shortened, finer strands that are the signature of pattern loss.

Blood tests are ordered when the picture suggests them. Mayo Clinic notes that testing may include thyroid function, iron studies and other markers depending on the history. Occasionally a small scalp biopsy, a sample of skin a few millimeters across, is taken when scarring conditions or inflammatory disease are possible.

The visit closes with a frank conversation about what the findings mean. If the diagnosis is pattern hair loss, the team usually proposes a medical trial and a timeline for reassessment. If a reversible cause turns up, that becomes the priority and the question of hair restoration is set aside until it is treated. Either way, the person leaves with a name for what is happening, which for many is the first real relief in months.

How hair loss treatment without surgery works at the follicle

Every hair on the scalp cycles through three phases. Anagen is the growth phase and lasts years. Catagen is a brief transition. Telogen is a resting phase of a few months, after which the hair falls out and the follicle starts again. MedlinePlus and Mayo Clinic both note that losing roughly 50 to 100 hairs a day is normal because a small fraction of follicles are always in the shedding stage.

Pattern hair loss disrupts this rhythm in a specific way. Follicles that are genetically sensitive to androgens, a group of hormones that includes dihydrotestosterone, gradually shrink. Each new growth phase is shorter and each new hair is finer, until the follicle produces little more than a wisp. The follicles are still there, which is why the process can often be slowed, but the visible hair gets thinner over years.

Non-surgical treatments intervene at different points. Some aim to lengthen the growth phase and improve blood flow around the follicle. Others block the hormonal signal that drives miniaturization. Device-based approaches try to stimulate the follicle directly with light or controlled micro-injury. Nutritional correction restores the raw materials a follicle needs when a genuine deficiency exists.

The common thread is time. Because a follicle completes a cycle over months, not days, any treatment has to be judged over the same horizon. Mayo Clinic advises that the widely used topical treatment for pattern loss needs at least six months before results can be assessed, and that oral treatment for men may take several months to show an effect. Anyone promising visible change in weeks is describing something other than follicle biology.

Who is usually offered medical treatment first, and who is asked to wait for surgery

Most people with a new diagnosis of pattern hair loss fall into the first group. Early or moderate thinning, a family history that fits, and a scalp that still holds plenty of miniaturized but living follicles are the classic reasons a team starts with medicine. The logic is simple: if those follicles can be nudged back toward a longer growth phase, there may be less ground to cover later, or no surgical ground at all.

Certain situations lead teams to hold off on any transplant discussion for now. Age is one. Hair loss in a person in their early twenties is still evolving, and the final pattern is hard to predict; a hairline designed for a 22-year-old scalp may look out of place at 45. Active shedding is another. Diffuse loss across the entire scalp, including the donor area, can signal a non-pattern cause or a form of pattern loss where donor hair itself is unstable. Scarring alopecias, autoimmune hair loss such as alopecia areata, and unmanaged medical conditions each need treatment in their own right before surgery is even a question.

Surgery tends to enter the conversation when three things line up. The diagnosis is confirmed pattern loss. The loss has been stable on medical treatment long enough for the team to trust the baseline, often a year or more in practice. And the back and sides hold enough dense, resistant hair to supply the area to be covered without leaving the donor zone visibly thin.

Being asked to wait is not a rejection. It is usually the team protecting a finite resource and refusing to operate on a scalp whose future shape is still unknown.

Medical treatment for hair loss: what the main medicines do and how long they take

Two categories of medicine dominate the evidence for pattern hair loss, and it helps to understand them by mechanism rather than by name.

The first is a topical vasodilator, minoxidil, applied to the scalp. Its exact action on hair is not fully understood, but it appears to prolong the growth phase and enlarge miniaturized follicles. Mayo Clinic notes it is available without prescription in the United States, that it helps some people regrow hair or slow further loss, and that it needs at least six months of continued use before benefit can be judged. Stopping it means the benefit fades. Some people notice extra shedding in the first weeks as resting hairs are pushed out ahead of new growth, a phenomenon clinicians expect and usually warn about.

The second category blocks the conversion of testosterone into dihydrotestosterone, the hormone most responsible for follicle shrinkage. Finasteride is the best-studied example and is prescription-only. The NHS describes it as a treatment for male pattern baldness that must be taken continuously to maintain any effect and that takes several months to show results. It is not offered to women who could become pregnant, and the NHS and Mayo Clinic both list possible side effects including changes in sexual function and mood that should be discussed with the prescriber.

Other medicines are sometimes used in women, including anti-androgen tablets and, in some cases, oral forms of minoxidil at low strengths under specialist supervision. Cleveland Clinic lists several of these among options for female pattern hair loss. Each carries its own monitoring requirements.

Which, if any, is appropriate is a decision for the prescribing clinician, weighed against a person’s health history and goals. What the medicines share is the requirement for patience and continuity.

Light devices, platelet-rich plasma and microneedling: what the evidence actually shows

This is the corner of hair restoration where marketing runs furthest ahead of data, so it is worth being precise.

Low-level laser or light devices, sold as combs, caps and helmets, deliver red light to the scalp with the aim of stimulating follicles. Mayo Clinic notes that a few small studies have shown these devices may improve hair density in hereditary hair loss, and that more research is needed to establish long-term effects. That is a fair summary: some evidence of modest benefit, not a proven equal to the medicines above.

Platelet-rich plasma, usually shortened to PRP, involves drawing a small amount of a person’s blood, spinning it to concentrate the platelets and growth factors, and injecting the concentrate into the scalp. Cleveland Clinic lists PRP among treatments used for hair loss, and Mayo Clinic describes it as an area of ongoing study. The trials that exist are small, use different preparation methods and injection schedules, and do not agree on how much benefit to expect or how long it lasts. It is reasonable to call PRP promising and under investigation; it is not reasonable to call it proven.

Microneedling uses a roller or pen with fine needles to create controlled micro-injuries in the scalp, on the theory that the healing response stimulates follicles and improves absorption of topical medicine. The published studies are mostly small and often combine microneedling with a topical treatment, which makes the independent effect hard to isolate.

Why this matters for someone weighing surgery: these approaches are often offered as add-ons, and a team may reasonably include one. But they are not a substitute for confirming the diagnosis or for the better-evidenced medicines, and none of them changes the fundamental need to stabilize loss before any transplant is planned.

Supplements, biotin and diet: separating a real deficiency from a marketing story

Walk down any pharmacy aisle and hair growth gummies outnumber the actual hair loss medicines by a wide margin. The evidence tells a more modest story.

Biotin is the most heavily promoted ingredient. The NIH Office of Dietary Supplements is clear that biotin deficiency is rare in people eating a varied diet, that deficiency can cause hair thinning, and that there is little evidence supplementation improves hair in people who are not deficient. The ODS also warns that high biotin intake can interfere with certain laboratory tests, including some thyroid and cardiac assays, which is a practical reason to tell a clinician about any supplement before blood work.

Iron is different. Low iron stores are a recognized contributor to hair shedding, particularly in women with heavy periods or restrictive diets, and MedlinePlus lists iron deficiency among the causes clinicians look for. Correcting a confirmed deficiency can help shedding settle. Taking iron without a confirmed deficiency, however, carries its own risks and should not be done on a hunch.

Vitamin D, zinc and protein intake come up in the research on hair loss, and a clinician may check levels when the history suggests a problem. Rapid weight loss, very low-calorie diets and eating disorders are well-documented triggers of a shedding pattern called telogen effluvium, in which a large number of follicles shift into the resting phase at once.

The honest summary: a supplement fixes a deficiency, not a genetic pattern. If tests show a shortfall, correcting it is part of good care. If they do not, the money spent on gummies is buying reassurance rather than follicles, and the delay in starting evidence-based treatment is the real cost.

Non-surgical options versus a hair transplant at a glance

Numbers and timelines are easier to hold side by side than in paragraphs, so the table below sets out how the main approaches compare on the questions people most often ask. The time-to-judge figures come from Mayo Clinic and NHS guidance; the evidence descriptions reflect what those sources and Cleveland Clinic report. Nothing here is a recommendation; suitability is a decision for the treating team.

Approach	What it does	Typical time before judging effect	Ongoing commitment	Strength of evidence
Topical minoxidil	Prolongs growth phase, may enlarge miniaturized follicles	At least 6 months (Mayo Clinic)	Continuous use; benefit fades if stopped	Established for pattern loss in men and women
Oral 5-alpha-reductase inhibitor (e.g., finasteride)	Reduces the hormone driving follicle shrinkage	Several months (NHS)	Continuous use; not for women who could become pregnant	Established for male pattern loss
Low-level light devices	Aims to stimulate follicles with red light	Months	Regular sessions indefinitely	Small studies suggest modest density gains (Mayo Clinic)
Platelet-rich plasma	Injects concentrated growth factors into scalp	Months	Repeat sessions	Under study; small, inconsistent trials
Nutritional correction	Restores a confirmed deficiency (iron, others)	Months, tied to hair cycle	Until levels normalize	Effective only when deficiency is present
Hair transplant	Relocates resistant follicles to thinning areas	Full result around 12 months	One or more procedures; medical treatment usually continues	Established for stable pattern loss with adequate donor supply

Two things stand out. Every non-surgical option is measured in months, which is why an impatient timeline undermines all of them. And the surgical row still lists ongoing medical treatment, because moving hair does not switch off the process that thinned it.

What the first weeks and months of non-surgical treatment usually look like

The early phase of medical treatment is a test of nerve more than anything else, because the first visible change is often the opposite of what people hope for.

In the first two to eight weeks on a topical treatment, some people notice more hair in the shower drain. This is commonly called shedding, and it happens because follicles in the resting phase are being pushed to release old hairs earlier so a new growth phase can begin. Clinicians expect it and usually mention it in advance. It is unsettling, and it is also the reason so many people stop treatment just as it is beginning to work.

By around three months, shedding has usually settled. The scalp may look no different yet. Under magnification a clinician might see fine new hairs beginning, but at arm’s length in a mirror there is often nothing to report. This is the stretch where daily photographs taken in the same light, from the same angle, earn their keep, because memory is a poor judge of gradual change.

Between six and twelve months is the window Mayo Clinic and the NHS describe for judging whether a treatment is helping. Some people see thickening at the crown or slowing of the temple recession. Others see stabilization without regrowth, which is still a meaningful result in a progressive condition. A minority see no change, and that finding is valuable too, because it tells the team the plan needs revisiting.

Follow-up visits typically cluster at the start and again around the half-year mark. Side effects, blood tests where relevant and photographs are reviewed. Only after this stretch does a well-run team usually feel confident enough in the baseline to discuss whether surgery has a place.

How non surgical hair restoration before transplant changes the surgical plan itself

People sometimes assume the medical phase is a hurdle to clear before the real work starts. In practice it reshapes the surgical plan in ways that are hard to overstate.

The first change is in the map. A scalp that has been stable on treatment for a year gives the surgeon a truer picture of where hair is going to be missing over the coming years. Hairlines can be placed with the future in mind rather than the present. Crown work, which is notoriously hungry for grafts, can be deferred or scaled if medicine has held the area.

The second change is in the arithmetic of supply. The donor area at the back and sides holds a finite number of follicles that can be moved safely without leaving visible thinning. Every follicle spent covering an area that medicine might have preserved is a follicle unavailable for future loss elsewhere. Stabilizing first means fewer grafts are needed for the same visual result, and more remain in reserve.

The third change is in what happens after surgery. Most teams that perform transplants advise continuing medical treatment afterward to protect the native hair between and behind the grafts. A person who has already established a routine, understood the side effects and learned to be patient with the hair cycle enters surgery far better prepared for that long-term commitment than someone starting everything at once.

Surgeons who take time to explain this are not being cautious for its own sake. They are describing the difference between a procedure that ages well and one that has to be repeatedly rescued. The medical phase is where that difference is decided.

Why "how many grafts" is the wrong first question, and what overharvesting means

Search results for hair transplants are full of graft counts, and it is natural to wonder whether a particular number is too many. The honest answer is that no number is safe or unsafe in isolation.

A graft is a small unit of scalp containing one to four follicles, removed from the donor area and placed where hair is missing. How many can be taken depends on the density of the donor zone, the size of the area it needs to cover, the caliber of the hair, and how much of that donor supply should be held back for future loss. Two people asking about the same figure could be in completely different situations: one with dense, coarse donor hair and a small target area, another with fine hair and a large, still-progressing pattern.

Overharvesting describes removing so many follicles from the donor area that it becomes visibly thin or patchy. Because donor hair does not regrow once moved, that thinning is permanent. It is a recognized risk of aggressive single-session surgery, particularly when the underlying loss has not been stabilized and the surgeon is trying to cover ground that is still shifting.

This is why the sequence matters. A team that has watched a scalp for a year on medical treatment can estimate the eventual pattern with more confidence, size the surgical plan to what the donor area can genuinely spare, and leave a reserve. A large graft count discussed at a first consultation, before diagnosis is confirmed and before any medical trial, is a signal to slow down and ask more questions.

Whether any specific count is appropriate is a judgment for the operating team, made with the donor area in front of them. It cannot be settled by a number on a screen.

What people often get wrong about non-surgical hair restoration

Several beliefs recur in consultations, and each one costs people either money or months.

“A transplant is permanent, so it fixes the problem.” The transplanted follicles usually keep growing because they came from a resistant area, but the surrounding native hair keeps thinning. Without ongoing medical treatment, the result can look excellent at one year and increasingly isolated at five.

“If a treatment were working, shedding would stop immediately.” The reverse is often true early on. Increased shedding in the first weeks of topical treatment is an expected phase, not a sign of failure. Mayo Clinic’s guidance that six months is the minimum judging period exists precisely because the early picture misleads.

“Supplements are a gentler first step.” Only if a deficiency exists. The NIH Office of Dietary Supplements finds little evidence that biotin helps people who are not deficient, and taking it can distort laboratory tests. Months on supplements before seeing a clinician is months of untreated progression.

“Non-surgical means low-evidence.” The best-supported hair loss treatments in medicine are non-surgical medicines with decades of study behind them. The low-evidence category is a subset of device and injection therapies, not the whole field.

“What a celebrity used will work for me.” No one outside a person’s care team knows what treatment they actually received, and a single public figure’s outcome is an anecdote, not data. Genetics, age, pattern, timing and adherence vary enormously.

“Women don’t get pattern hair loss.” Cleveland Clinic describes female pattern hair loss as common, presenting as widening of the parting and diffuse thinning over the top rather than a receding hairline. It is frequently missed or dismissed, which delays evaluation.

Hair transplant alternatives that do not involve medicine or surgery

Not everyone wants a medicine that requires daily use for life, and not everyone is a surgical candidate. A third group of options changes how hair loss looks rather than how follicles behave, and for some people that is the right fit.

Scalp micropigmentation is a cosmetic tattooing technique in which tiny dots of pigment are placed in the scalp to mimic the appearance of closely shaved hair or to reduce the contrast between thinning hair and skin. It does not grow hair, it needs occasional touch-ups as pigment fades, and it sits best on people who are comfortable with a very short style. The NHS lists tattooing among the options people consider for hair loss.

Hair systems, sometimes marketed as non-surgical hair replacement, are custom pieces attached to the scalp with adhesive or clips and blended with existing hair. Modern versions can look natural, but they require regular maintenance, periodic replacement and attention to scalp skin under the attachment.

Cosmetic fibers and tinted powders cling to existing hair to create the impression of density. They wash out, cost nothing in terms of health risk, and can be a useful bridge during the months when medical treatment has not yet shown its effect.

Wigs and hairpieces remain the most complete cosmetic option and are especially relevant for people with extensive, scarring or autoimmune hair loss where regrowth is unlikely. The NHS notes that in some circumstances wigs may be available through health services for people whose hair loss is medically related.

None of these options interferes with a later decision about medicine or surgery, and a good care team will discuss them without judgment. Wanting to look a certain way in the meantime is not vanity; it is a reasonable response to a visible change.

Questions to ask your care team before agreeing to any plan

A first consultation is easier to steer with a short list in hand. The questions below are designed to surface the reasoning behind a plan rather than just its contents.

• What is my diagnosis, and how confident are you in it? Is there any test that would change your mind?
• Have reversible causes such as thyroid disease, iron deficiency or medication effects been considered or tested for?
• Which non-surgical treatment are you proposing, how does it work, and how long before we can fairly judge whether it is helping?
• What side effects should I watch for, and which of them would you want to hear about straight away?
• How will we measure progress? Will you take standardized photographs or use magnification at follow-up?
• If I stop the treatment, what typically happens to any gains?
• At what point, if ever, would you consider me a candidate for a transplant, and what would need to be true first?
• How much donor hair do I have, and how does that limit what surgery could realistically achieve now and in the future?
• If you are recommending a device or injection therapy, what does the published evidence show, and how does its strength compare with the medicines?
• Who do I contact between visits if something worries me?

Pay attention to how the answers are given as much as to their content. A team that welcomes the question about evidence, explains uncertainty plainly and is willing to say “not yet” about surgery is showing the kind of judgment that protects people over the long run. A conversation that moves quickly to graft numbers and scheduling, before diagnosis and a medical trial have been discussed, deserves a second opinion.

When to call your doctor

Most hair loss is gradual and, while distressing, not medically urgent. Certain patterns and symptoms, however, point to something that needs prompt evaluation rather than a wait-and-see approach with over-the-counter products.

Contact a clinician soon if hair is coming out in sudden clumps or if a large increase in daily shedding started over a few weeks. Rapid onset is more typical of telogen effluvium, autoimmune loss or a medication effect than of pattern loss, and the sooner the trigger is identified the better. Mayo Clinic advises seeking care for sudden or patchy loss and for loss that is more than usual when combing or washing.

Seek evaluation for patchy, coin-shaped bald areas; for a scalp that is red, scaly, painful, itchy or has pustules; for hair loss accompanied by broken hairs at the surface; or for loss that includes eyebrows, eyelashes or body hair. These can indicate inflammatory or scarring conditions where early treatment matters because destroyed follicles do not recover.

Do not delay if hair loss comes with other changes: unexplained weight change, fatigue, feeling unusually cold or hot, changes in menstrual cycles, new facial hair growth or acne in women, or a rash elsewhere on the body. These combinations can point to thyroid disease, hormonal conditions or systemic illness that need their own workup.

Anyone already on a prescribed hair loss medicine should report new mood changes, sexual side effects, chest pain, palpitations, dizziness, swelling of the ankles or a scalp reaction to the prescriber rather than stopping or adjusting the medicine on their own.

Finally, if hair loss is causing significant anxiety, low mood or avoidance of daily life, that is a valid reason to seek help in itself. Treating teams take the emotional weight of hair loss seriously, and support is part of good care.

Frequently asked questions

Is a hair transplant necessary if hair is thinning?

Usually not as a first step. Pattern hair loss is progressive, and clinicians typically confirm the diagnosis, check for reversible causes, and trial medical treatment for around six to twelve months before surgery is discussed. Many people find that stabilizing the loss with medicine is enough for their goals, while others go on to surgery with a smaller, better-planned procedure because the background thinning has been controlled.

What did Elon Musk or Jennifer Lopez use to regrow their hair?

No one outside their care teams knows, and any specific claim online is speculation. Public figures rarely publish medical records, and a single person’s result reflects their genetics, age, pattern and adherence, none of which transfer to anyone else. The evidence that matters comes from controlled studies of treatments in many people, which is what Mayo Clinic and the NHS summarize, not from a celebrity’s appearance across two photographs.

How much does non-surgical hair restoration or grafting typically cost?

This article does not publish costs, because they vary widely by country, health system, diagnosis and the specific plan a team proposes, and a figure quoted here would be misleading. A clinician or care coordinator can give an itemized estimate after evaluation. What is worth knowing beforehand is that medical treatment for pattern loss is a long-term commitment, so any estimate should account for years of continued use rather than a single purchase.

Is 5000 grafts overharvesting?

No graft count is safe or unsafe on its own. Overharvesting means removing so many follicles that the donor area becomes visibly thin, and the threshold depends on donor density, hair caliber, the size of the target area and how much reserve should be kept for future loss. A large number proposed at a first visit, before diagnosis is confirmed and medical treatment has stabilized the loss, is a reason to slow down and seek a second opinion.

Is hair loss treatment without surgery effective for women?

Topical minoxidil is an established treatment for female pattern hair loss, and Cleveland Clinic lists several other medical options that specialists may consider depending on age, health and whether pregnancy is possible. Women are often evaluated for iron deficiency, thyroid disease and hormonal conditions first, because these are more frequent contributors to shedding in women. Which treatment fits is a decision for the prescribing clinician after examination and any needed tests.

How long does medical treatment for hair loss take to show results?

Months, because each follicle completes a growth cycle over that timescale. Mayo Clinic advises at least six months of topical minoxidil before assessing benefit, and the NHS describes several months for finasteride in men. Early weeks may bring extra shedding rather than regrowth. Standardized photographs taken in the same light every few weeks help track gradual change that the mirror and memory reliably miss.

Do I have to keep using hair loss medicine after a transplant?

Most teams advise continuing, because transplanted follicles resist hormonal thinning but the native hair around them does not. Without ongoing treatment the surrounding hair keeps miniaturizing on its own schedule, and the grafted area can become isolated over years. The NHS and Mayo Clinic both note that benefits of these medicines fade when they are stopped. Any change to a prescribed regimen should be discussed with the prescribing clinician.

Does PRP or laser therapy count as proven hair transplant alternatives?

Not yet at the level of the established medicines. Mayo Clinic notes that small studies suggest low-level light devices may improve hair density and that platelet-rich plasma is still being studied. Trials of PRP use different preparations and schedules and reach inconsistent conclusions. These approaches may be offered as add-ons by a care team, but they do not replace confirming the diagnosis or the better-evidenced treatments.

Will biotin or hair growth supplements help my thinning hair?

Only if a deficiency is present. The NIH Office of Dietary Supplements states that biotin deficiency is rare in people eating a varied diet and that there is little evidence supplementation helps hair in people who are not deficient. High biotin intake can also interfere with some thyroid and cardiac laboratory tests. Iron deficiency, by contrast, is a recognized contributor to shedding and is worth testing for when the history suggests it.

Why did I shed more hair after starting treatment?

Increased shedding in the first weeks of topical treatment is a recognized and usually temporary phase. The medicine appears to push follicles in the resting stage to release old hairs sooner so a new growth cycle can begin, which means more hair in the drain before any thickening appears. Clinicians expect this and typically warn about it. If shedding is heavy, prolonged beyond a couple of months, or accompanied by scalp irritation, contact the prescribing clinician.

References

• NHS: Hair loss
• MedlinePlus: Hair loss
• Cleveland Clinic: Hair loss in women

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.